Year |
Citation |
Score |
2019 |
Berdan CA, Ho R, Lehtola HS, To M, Hu X, Huffman TR, Petri Y, Altobelli CR, Demeulenaere SG, Olzmann JA, Maimone TJ, Nomura DK. Parthenolide Covalently Targets and Inhibits Focal Adhesion Kinase in Breast Cancer Cells. Cell Chemical Biology. PMID 31080076 DOI: 10.1016/J.Chembiol.2019.03.016 |
0.58 |
|
2017 |
Grossman EA, Ward CC, Spradlin JN, Bateman LA, Huffman TR, Miyamoto DK, Kleinman JI, Nomura DK. Covalent Ligand Discovery against Druggable Hotspots Targeted by Anti-cancer Natural Products. Cell Chemical Biology. PMID 28919038 DOI: 10.1016/J.Chembiol.2017.08.013 |
0.592 |
|
2017 |
Bateman LA, Nguyen TB, Roberts AM, Miyamoto DK, Ku WM, Huffman TR, Petri Y, Heslin MJ, Contreras CM, Skibola CF, Olzmann JA, Nomura DK. Chemoproteomics-enabled covalent ligand screen reveals a cysteine hotspot in reticulon 4 that impairs ER morphology and cancer pathogenicity. Chemical Communications (Cambridge, England). PMID 28352901 DOI: 10.1039/C7Cc01480E |
0.581 |
|
2017 |
Roberts AM, Miyamoto DK, Huffman TR, Bateman LA, Ives AN, Heslin MJ, Akopian D, Contreras CM, Rape M, Skibola CF, Nomura DK. Chemoproteomic Screening of Covalent Ligands Reveals UBA5 as a Novel Pancreatic Cancer Target. Acs Chemical Biology. PMID 28186401 DOI: 10.1021/Acschembio.7B00020 |
0.565 |
|
2016 |
Louie SM, Grossman EA, Crawford LA, Ding L, Camarda R, Huffman TR, Miyamoto DK, Goga A, Weerapana E, Nomura DK. GSTP1 Is a Driver of Triple-Negative Breast Cancer Cell Metabolism and Pathogenicity. Cell Chemical Biology. PMID 27185638 DOI: 10.1016/J.Chembiol.2016.03.017 |
0.544 |
|
Show low-probability matches. |